A tighter archive for life-science signals.
Search once, then narrow by source or topic.
FDA raises CAR-T approval standards; Novartis bets on an AI startup
FDA raises CAR-T approval standards; Novartis bets on an AI startup
J&J’s ‘remarkable’ Tecvayli data support earlier use in multiple myeloma
J&J’s ‘remarkable’ Tecvayli data support earlier use in multiple myeloma
Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment
Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment
Mirum gains a hepatitis D drug in $620M buyout of startup Bluejay
Mirum gains a hepatitis D drug in $620M buyout of startup Bluejay
Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar
Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar
How digital companion apps unlock value across the drug lifecycle
How digital companion apps unlock value across the drug lifecycle
At ASH, Lilly makes case to widen Jaypirca use in leukemia, lymphoma
At ASH, Lilly makes case to widen Jaypirca use in leukemia, lymphoma
Vertex CRISPR therapy hits early goal in children with blood disorders
Vertex CRISPR therapy hits early goal in children with blood disorders
RFK Jr.’s hand-picked panel questions childhood vaccine schedule
RFK Jr.’s hand-picked panel questions childhood vaccine schedule
Hemophilia gene therapies are struggling on the market, even as innovation soars
Hemophilia gene therapies are struggling on the market, even as innovation soars
Praxis soars higher; Bristol Myers’ CAR-T therapy wins broader use
Praxis soars higher; Bristol Myers’ CAR-T therapy wins broader use
CDC panel again postpones vote on newborns’ hepatitis B shot
CDC panel again postpones vote on newborns’ hepatitis B shot
An Arch-backed biotech raises $53M to fight neurodegeneration
An Arch-backed biotech raises $53M to fight neurodegeneration
12 former FDA chiefs blast Prasad’s move to toughen vaccine standards
12 former FDA chiefs blast Prasad’s move to toughen vaccine standards
Tracey Beth Høeg, top Makary deputy, named head of FDA drug office
Tracey Beth Høeg, top Makary deputy, named head of FDA drug office
UniQure slides further on outlook for Huntington’s gene therapy
UniQure slides further on outlook for Huntington’s gene therapy
After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis
After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis
Capricor soars on positive results for Duchenne cell therapy
Capricor soars on positive results for Duchenne cell therapy
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page